Page 31 - 2019_09-HaematologicaMondo-web

Hemophilia A and B: sharing differences
42. Cooley B, Funkhouser W, Monroe D, et al. Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice. Blood. 2016;128(2):286-292.
43. Gui T, Lin H-F, Jin D-Y, et al. Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo. Blood. 2002;100(1):153-158.
44. Bolton-Maggs PHB, Pasi KJ. Haemophilias A and B. Lancet. 2003;361(9371):1801-1809.
45. Dimichele DM. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis. Haemophilia. 2006;12 Suppl 6:37-42.
46. Hay CRM, DiMichele DM, International Immune Tolerance Study. The principal results of the International Immune Tolerance Study: a randomized dose com- parison. Blood. 2012;119(6):1335-1344.
47. Dimichele D. The North American Immune Tolerance registry: contributions
to the thirty-year experience with immune tolerance therapy. Haemophilia. 2009;15 (1):320-328
48. Lee CA, Kessler CM, Varon D, Martinowitz U, Heim M, Warrier I. Management of haemophilia B patients with inhibitors and anaphylaxis. Haemophilia. 1998;4(4):574-576.
49. Tengborn L, Hansson S, Fasth A, Lübeck PO, Berg A, Ljung R. Anaphylactoid reac- tions and nephrotic syndrome--a consider- able risk during factor IX treatment in patients with haemophilia B and inhibitors: a report on the outcome in two brothers. Haemophilia. 1998;4(6):854-859.
50. Alexander S, Hopewell S, Hunter S, Chouksey A. Rituximab and desensitiza- tion for a patient with severe factor IX defi- ciency, inhibitors, and history of anaphy- laxis. J Pediatr Hematol Oncol. 2008;30
(1):93–95.
51. Gill JC, Roberts J, Li Y, Castaman G.
Sustained high trough factor IX activity lev- els with continued use of rIX-FP in adult and paediatric patients with haemophilia B. Haemophilia. 2019 Mar 13. [Epub ahead of print]
52. Gouw SC, van den Berg HM, Oldenburg J, et al. F8 gene mutation type and inhibitor development in patients with severe hemo- philia A: systematic review and meta- analysis. Blood. 2012;119:2922-2934.
53. Brummel-Ziedins KE, Mann KG. Overview of hemostasis. In Lee CA, Berntorp EE, Hoots WK. Textbook of haemophilia, 3rd edition, pages 1-8, Wiley-Blacwell, London, UK, 2014.
54. Nazeef M, Sheehan JP. New developments in the management of moderate-to-severe hemophilia B. J Blood Med. 2016;7:27-38.
haematologica | 2019; 104(9)
1709